Mariner, LLC Abb Vie Inc. Transaction History

Mariner, LLC

$51.1 Billion
Q2 2024

A detailed history of Mariner, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mariner, LLC holds 1,022,750 shares of ABBV stock, worth $197 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

1,022,750

Previous 986,039 3.72%

Holding current value

$197 Million

Previous $180 Million 2.3%

% of portfolio

0.34%

Previous 0.37%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $5.68 Million - $6.64 Million	36,711 Added 3.72%	1,022,750 $175 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $614,507 - $700,174	-3,845 Reduced 0.39%	986,039 $180 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $6.31 Million - $7.1 Million	45,835 Added 4.86%	989,884 $153 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $6.05 Million - $7 Million	45,294 Added 5.04%	944,049 $141 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $3.15 Million - $3.93 Million	23,804 Added 2.72%	898,755 $121 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $6.73 Million - $7.75 Million	46,528 Added 5.62%	874,951 $139 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $14.5 Million - $17.4 Million	104,993 Added 14.51%	828,423 $134 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $5.21 Million - $5.98 Million	38,847 Added 5.67%	723,430 $97.1 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $10.3 Million - $13.1 Million	75,061 Added 12.31%	684,583 $105 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $30.5 Million - $37.9 Million	231,465 Added 61.22%	609,522 $98.8 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $5.92 Million - $7.5 Million	55,149 Added 17.08%	378,057 $51.2 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $2.91 Million - $3.3 Million	27,303 Added 9.24%	322,908 $34.8 Million
Q2 2021 Aug 24, 2021	BUY	$105.21 - $117.21 $954,991 - $1.06 Million	9,077 Added 3.17%	295,605 $33.3 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $1.02 Million - $1.12 Million	9,929 Added 3.59%	286,528 $31 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $2.1 Million - $2.83 Million	26,053 Added 10.4%	276,599 $29.6 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $23.3 Million - $27.4 Million	-271,281 Reduced 51.99%	250,546 $21.9 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $848,670 - $1.14 Million	11,567 Added 2.27%	521,827 $51.2 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $20.8 Million - $31.5 Million	322,172 Added 171.29%	510,260 $38.9 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $1.39 Million - $1.74 Million	19,327 Added 11.45%	188,088 $16.7 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $897,905 - $1.08 Million	-14,257 Reduced 7.79%	168,761 $12.8 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $2.38 Million - $3.04 Million	36,247 Added 24.7%	183,018 $13.3 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $423,498 - $498,437	5,490 Added 3.89%	146,771 $11.8 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $5.17 Million - $6.37 Million	66,362 Added 88.58%	141,281 $13 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $756,624 - $841,128	8,510 Added 12.81%	74,919 $7.09 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $1.55 Million - $1.84 Million	17,296 Added 35.22%	66,409 $6.15 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $1.66 Million - $2.23 Million	18,076 Added 58.24%	49,113 $4.65 Million
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $1.54 Million - $1.69 Million	17,167 Added 123.77%	31,037 $3 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $968,819 - $1.24 Million	13,870	13,870 $1.23 Million

Others Institutions Holding ABBV

# of Institutions

3,693

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account